COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron SurgeWilla Cochran, Robin K. Avery, Dillon Goddard et al.|Transplantation|2022Cited by 25